Georgios Ponirakis, PhD 🇺🇦

512 posts

Georgios Ponirakis, PhD 🇺🇦 banner
Georgios Ponirakis, PhD 🇺🇦

Georgios Ponirakis, PhD 🇺🇦

@GPonirakis

Researcher @WCMQatar tweets about corneal confocal microscopy #CCM research a diagnostic biomarker for #neurodegenerative diseases

Doha, Qatar 🇶🇦 Katılım Ekim 2013
4K Takip Edilen4.6K Takipçiler
Georgios Ponirakis, PhD 🇺🇦
Our intuition often misleads us into thinking that general obesity carries the same risk as central obesity. Our study shows that visceral, not subcutaneous, fat drives peripheral #neuropathy through diabetes, hypertension, inflammation, and vascular disease.
Georgios Ponirakis, PhD 🇺🇦 tweet media
English
2
1
1
312
Georgios Ponirakis, PhD 🇺🇦
X was once a valuable platform for exchanging ideas. However, with the amplification of misinformation, others getting buried, and the owner’s retweeting of false content, it is no longer a platform for meaningful conversations.
Georgios Ponirakis, PhD 🇺🇦 tweet mediaGeorgios Ponirakis, PhD 🇺🇦 tweet mediaGeorgios Ponirakis, PhD 🇺🇦 tweet media
English
0
0
1
273
Georgios Ponirakis, PhD 🇺🇦 retweetledi
ENA Group 👁️
ENA Group 👁️@GroupENA·
As AI advances in the analysis of corneal nerve morphology, @Yiannaras et al., from Prof. @Rayazamalik's lab, showed that corneal confocal microscopy (CCM) can distinguish patterns of neurodegeneration in multiple sclerosis and epilepsy. Read more: pubmed.ncbi.nlm.nih.gov/39671224/
ENA Group 👁️ tweet media
English
1
1
4
398
Georgios Ponirakis, PhD 🇺🇦
Pleasure to present on neuropathy in prediabetes & diabetes at the 29th TMIMS international symposium: a new era for diagnosis and treatment of #diabetic_neuropathy at the Tokyo Metropolitan Institute of Medical Science. Thank you Dr Odriozola & Dr Sango for the kind invitation!
Georgios Ponirakis, PhD 🇺🇦 tweet media
English
0
1
11
646
Georgios Ponirakis, PhD 🇺🇦
Honored to celebrate 10 years at Weill Cornell Medicine-Qatar! Proud to contribute to CCM research on neurological disorders with Prof. Malik's team and mentor medical students through the AOC program. Grateful for the journey and the impact we've made together!
Georgios Ponirakis, PhD 🇺🇦 tweet media
English
0
2
11
814
Georgios Ponirakis, PhD 🇺🇦 retweetledi
Neurodiab
Neurodiab@Neurodiab_eu·
Weight management in diabetes: study highlights neuroprotective role of weight loss medications On Neurodiab website a signaling of articles on #diabeticneuropathy The 149th NEUROdiab Publication News is by Mette Krabsmark Borbjerg (neurodiab.eu/publication-ne……)
Neurodiab tweet media
English
0
6
8
583
Georgios Ponirakis, PhD 🇺🇦 retweetledi
Peripheral Nerve Society (PNS)
Choosing diabetes medications that promote weight loss may help reduce nerve damage, improve long-term outcomes for patients. Weight management is crucial in diabetes care.
English
0
2
2
308
Georgios Ponirakis, PhD 🇺🇦 retweetledi
Peripheral Nerve Society (PNS)
Their study found that people with type 2 diabetes on medications that cause weight gain had worse nerve damage and a greater loss of corneal nerves over time compared to those on weight loss medications.
English
1
2
2
309
Georgios Ponirakis, PhD 🇺🇦 retweetledi
Peripheral Nerve Society (PNS)
Obesity is a major risk factor for diabetic peripheral neuropathy (DPN) in type 2 diabetes. This study investigated the effect of glucose lowering medication associated with weight change on DPN.
English
1
2
2
254